Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises, and performance

Regulatory Toxicology and Pharmacology

Volumn 28, Issue 2, 1998, Pages 85-95

  Zeiger, Errol ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

AMES TEST; ARTICLE; CARCINOGEN TESTING; CHROMOSOME ABERRATION; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; RODENT; TOXICITY TESTING;

MAMMALIA; RODENTIA; SALMONELLA;

EID: 0032465960     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1234     Document Type: Article

References (68)

1. Ashby J. Precedents or possibilities: Which should guide the harmonization of mutagenicity test protocols and carcinogen prediction strategies. Mutat. Res. 298:1993;291-295.
2. Ashby J., Tennant R. W. Definitive relationships among chemical structure, carcinogenicity, and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257:1991;229-306.
3. Auletta A., Ashby J. Workshop on the relationship between short-term test information and carcinogenicity, Williamsburg, Virginia, January 20-23, 1987. Environ. Mol. Mutagen. 11:1988;135-146.
4. Auletta A. E., Dearfield K. L., Cimino M. C. Mutagenicity test schemes and guidelines: U.S. EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs. Environ. Mol. Mutagen. 21:1993;38-45.
5. Balls M., Blaauboer B. J., Brusick D., Frazier J., Lamb D., Pemberton M., Reinhardt C., Roberfroid M., Rosenkranz H., Schmid B., Spielmann H., Stammati A.-L., Walum E. Report and recommendations of the CAAT/ERGATT Workshop on the Validation of Toxicity Test Procedures. ATLA. 18:1990;313-337.
6. Balls M., Blaauboer B. J., Fentem J. H., Bruner L., Combes R. D., Ekwall B., Fielder R. J., Guillouzo A., Lewis R. W., Lovell D. P., Reinhardt C. A., Repetto G., Sladowski D., Spielmann H., Zucco F. Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM Workshop 5. ATLA. 23:1995;129-147.
7. Benigni R. Analysis of the National Toxicology Program data onin vitro. Mutagenesis. 4:1989;412-419.
8. Benigni R. Relationships betweenin vitro. Mutagenesis. 7:1992;335-341.
9. Bridges B. A. Some general principles of mutagenicity screening and a possible framework for testing procedures. Environ. Health Perspect. 6:1973;221-227.
10. Brown L. P., Ashby J. Correlations between bioassay dose-level, mutagenicity to Salmonella, chemical structure and sites of carcinogenesis among 226 chemicals evaluated for carcinogenicity by the U.S. NTP. Mutat. Res. 244:1990;67-76.
11. Caspary W. J., Lee Y. J., Poulton S., Myhr B. C., Mitchell A. D., Rudd C. J. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Quality-control guidelines and response categories. Environ. Mol. Mutagen. 12:1988;19-36.
12. Chhabra R. S., Huff J. E., Schwetz B. S., Selkirk J. An overview of prochronic and chronic toxicity/carcinogenicity experimental designs and criteria used by the National Toxicology Program. Environ. Health Perspect. 86:1990;313-321.
13. Clive D., Johnson K. O., Spector J. F. S., Batson A. G., Brown M. M. M. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat. Res. 59:1979;61-108.
14. Clive D., McCuen R., Spector J. F. S., Piper C., Mavournin K. H. Specific gene mutations in L5178Y cells in culture. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 115:1983;225-251.
15. Combes R. D., Stopper H., Caspary W. D. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals. Mutagenesis. 10:1995;403-408.
16. Dearfield K. L., Auletta A. E., Cimino M. C., Moore M. M. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat. Res. 258:1991;259-283.
17. Dunkel V. C., Zeiger E., Brusick D., McCoy E., McGregor D., Mortelmans K., Rosenkranz H., Simmon V. F. Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens inSalmonella typhimuriumEscherichia coli. Environ. Mol. Mutagen. 7:1985;1-248.
18. Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. 1993.
19. Flamm W. G. A tier system approach to mutagen testing. Mutat. Res. 26:1974;329-333.
20. Fung V. A., Huff J., Weisburger E. K., Hoel D. G. Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: Scientific and public health impact. Fundam. Appl. Toxicol. 20:1993;413-436.
21. Galloway S. M., Bloom A. D., Resnick M., Margolin B. H., Nakamura F., Archer P., Zeiger E. Development of a standard protocol forin vitro. Environ. Mutagen. 7:1985;1-52.
22. Galloway S. M., Armstrong M. J., Reuben C., Colman S., Brown B., Cannon C., Bloom A. D., Nakamura F., Ahmed M., Duk S., Rimpo J., Margolin B. H., Resnick M. A., Anderson B., Zeiger E. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagen. 10:1987;1-176.
23. GAO (United States General Accounting Office), 1993, Pesticides. A Comparative Study of Industrialized Nations' Regulatory Systems.
24. Glatt H. Comparison of common gene mutation tests in mammalian cells in culture: A position paper of the GUM Commission for the Development of Guidelines for Genotoxicity Testing. Mutat. Res. 313:1994;7-20.
25. Gold L. S., Zeiger E. Handbook of Carcinogenic Potency and Genotoxicity Databases. 1997;CRC Press, Boca Raton.
26. Gorelick N. J., Tindall K. R., Glickman B. W. State of the art in transgenic animals in mutation research. Environ. Mol. Mutagen. 28:1996;295-298.
27. Heddle J. A., Hite M., Kirkhart B., Mavournin K. H., MacGregor J. T., Newell G. W., Salamone M. F. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox program. Mutat. Res. 123:1983;61-118.
28. Hollstein M., McCann J., Angelosanto F., Nichols W. Short-term tests for carcinogens and mutagens. Mutat. Res. 65:1979;133-226.
29. Environ. Mol. Mutagen. 21:1993;15-37.
30. Huff J. E., Haseman J. K., McConnell E. E., Moore J. A. The National Toxicology Program, toxicology data evaluation techniques, and long-term carcinogenesis studies. Safety Evaluation of Drugs and Chemicals. 1986;Hemisphere, Washington. p. 411-446.
31. Monographs on the Evaluation of Carcinogenic Risks to Humans. 1987;International Agency for Research on Cancer, Lyon.
32. ICCVAM, 1997, Validation and Regulatory Acceptance of Toxicological Test Methods, National Institute of Environmental Health Sciences, 0NIH, DHHS, http://ntp-server.niehs.nih.gov/htdocs/ICCVAM/ICCVAM.html.
33. Kier L. D., Brusick D. J., Auletta A. E., Von Halle E. S., Simmon V. F., Brown M. M., Dunkel V. C., McCann J., Mortelmans K., Prival M. J., Rao T. K., Ray V. A. TheSalmonella typhimurium. Mutat. Res. 168:1986;67-238.
34. Kirkland D. J. Genetic toxicology testing requirements: Official and unofficial views from Europe. Environ. Mol. Mutagen. 21:1993;8-14.
35. Kluwe W. M. The complementary roles ofin vitroin vivo. Regul. Toxicol. Pharmacol. 22:1995;268-272.
36. Kramers P. G. N., Knaap A. G. A. C., van der Heijden C. A., Taalman R. D. F. M., Mohn G. R. Role of genotoxicity assays in the regulation of chemicals in The Netherlands: Considerations and experiences. Mutagenesis. 6:1991;487-493.
37. Li A. P., Aaron C. S., Auletta A. E., Dearfield K. L., Riddle J. C., Slesinski R. S., Stankowski L. F. Jr. An evaluation of the roles of mammalian cell mutation assays in the testing of chemical genotoxicity. Regul. Toxicol. Pharmacol. 14:1991;24-40.
38. Lohman P. H. M., Mendelsohn M. L., Moore D. H. II, Waters M. D., Brusick D. J., Ashby J., Lohman W. J. A. A method for comparing and combining short-term genotoxicity test data: The basic system. Mutat. Res. 266:1992;7-25.
39. Madle S. Problem of the harmonization of philosophies for genotoxicity screening. Mutat. Res. 300:1993;73-76.
40. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens in the Salmonella/microsome test: Assay of 300 chemicals. Proc. Natl. Acad. Sci. USA. 72:1975;5135-5139.
41. +/-. Mutat. Res. 394:1997;177-303.
42. Mitchell A. D., Myhr B. C., Rudd C. J., Caspary W. J., Dunkel V. C. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Methods used and chemicals evaluated. Environ. Mol. Mutagen. 12:1988;1-18.
43. Morita T., Asano N., Awogi T., Sasaki Yu. F., Sato S.-I., Shimada H., Sutou S., Suzuki T., Wakata A., Sofuni T., Hayashi M. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS.MMS. Mutat. Res. 389:1997;3-122.
44. Mrak, E. M. 1969, Mutagenicity of pesticides, Report of the Secretary's Commission on Pesticides and Their Relationship to Environmental Health, 565, 654, U.S. Department of Health, Education, and Welfare.
45. OECD, 1996, Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Methods, Organization for Economic Co-operation and Development, Paris.
46. In VitroIn Vitro. 1997.
47. Preston R. J., Au W., Bender M. A., Brewen J. G., Carrano A. V., Heddle J. A., McFee A. F., Wolff S., Wassom J. S. Mammalianin vivoin vitro. Mutat. Res. 87:1981;143-188.
48. Purchase I. F. H., Longstaff E., Ashby J., Styles J. A., Anderson D., Lefevre P. A., Westwood F. R. An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Br. J. Cancer. 37:1978;873-959.
49. Ray V. A., Kier L. D., Kannan K. L., Haas R. T., Auletta A. E., Wassom J. S., Nesnow S., Waters M. D. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: Class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of Phase II of the U.S. Environmental Protection Agency Gene-Tox program. Mutat. Res. 185:1987;197-241.
50. Rinkus S. J., Legator M. S. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in theSalmonella typhimurium. Cancer Res. 39:1979;3289-3318.
51. Rosenkranz H. S., Ennever F. K., Klopman G. Relationship between carcinogenicity in rodents and the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Mutagenesis. 5:1990;559-571.
52. Selkirk J. K., Soward S. M. Compendium of abstracts from long-term cancer studies reported by the National Toxicology Program from 1976 to 1992. Environ. Health Perspect. 101:1993;3-281.
53. Shelby M. D. Selecting chemicals and assays for assessing mammalian germ cell mutagenicity. Mutat. Res. 352:1996;159-167.
54. Shelby M. D., Erexson G. L., Hook G. J., Tice R. R. Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ. Mol. Mutagen. 21:1993;160-179.
55. Shelby M. D., Zeiger E. Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat. Res. 234:1990;257-261.
56. Sofuni T. Japanese guidelines for mutagenicity testing. Environ. Mol. Mutagen. 21:1993;2-7.
57. Sontag, J. M. Page, N. P. Saffioti, U. 1976, Guidelines for Carcinogen Bioassay in Small Rodents, U.S. DHEW, Washington, DC.
58. Sugimura T., Sato S., Nagao M., Yahagi T., Matsushima T., Seino Y., Takeuchi M., Kawachi T. Overlapping of carcinogens and mutagens. Magee P. N., Takayama S., Sugimura T., Matsushima T. Fundamentals of Cancer Prevention. 1976;191-215 University Park Press, Baltimore.
59. Tennant R. W. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. Mutat. Res. 286:1993;111-118.
60. Tennant R. W., Margolin B. H., Shelby M. D., Zeiger E., Haseman J. K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents fromin vitro. Science. 236:1987;933-941.
61. Tice R. R., Erexson G. L., Shelby M. D. The induction of micronucleated polychromatic erythrocytes in mice using single and multiple treatments. Mutat. Res. 234:1990;187-194.
62. Waters M. D., Stack H. F., Jackson M. A., Bridges B. A., Adler I.-D. The performance of short-term tests in identifying potential germ cell mutagens: A qualitative and quantitative analysis. Mutat. Res. 341:1994;109-131.
63. Weisburger E. K. History of the bioassay program of the National Cancer Institute. Prog. Exp. Tumor Res. 26:1983;187-201.
64. Zeiger E. Carcinogenicity of mutagens: Predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. Cancer Res. 47:1987;1287-1296.
65. Zeiger E. Genotoxicity database. Gold L. S., Zeiger E. Handbook of Carcinogenic Potency and Genotoxicity Databases. 1997;687-729 CRC Press.
66. Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ. Mol. Mutagen. 19:1992;2-141.
67. Zeiger E., Drake J. W. An environmental mutagenesis test development programme. Montesano R., Bartsch H., Tomatis L. Molecular and Cellular Aspects of Carcinogen Screening Tests. 1980;303-313.
68. Zeiger E., Haseman J. K., Shelby M. D., Margolin B. H., Tennant R. W. Evaluation of fourin vitro. Environ. Mol. Mutagen. 16:1990;1-14.